Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NICE-40 in Relapsed/Refractory Hodgkin Lymphoma
NCT04981899Phase 2Completed
- Sponsor
- First Saint Petersburg State Medical University
- Start
- Mar 2021
- Primary completion
- May 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab in Hodgkin lymphoma (HL), sponsored by First Saint Petersburg State Medical University. Started Mar 2021; status: completed.
02
Drugs
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT04981899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04981899.